首页> 外文OA文献 >Mechanism of Action of a Novel Series of Naphthyridine-Type Ribosome Inhibitors: Enhancement of tRNA Footprinting at the Decoding Site of 16S rRNA
【2h】

Mechanism of Action of a Novel Series of Naphthyridine-Type Ribosome Inhibitors: Enhancement of tRNA Footprinting at the Decoding Site of 16S rRNA

机译:一系列新型的萘啶型核糖体抑制剂的作用机制:在16S rRNA的解码位点的tRNA足迹的增强。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The novel ribosome inhibitors (NRIs) are a broad-spectrum naphthyridine class that selectively inhibits bacterial protein synthesis (P. J. Dandliker et al., Antimicrob. Agents Chemother. 47:3831-3839, 2003). Footprinting experiments, using a range of NRIs and chemical modification agents on Escherichia coli ribosomes, revealed no evidence for direct protection of rRNA. In the presence of tRNA, however, we found that NRIs enhanced the known ribosomal footprinting pattern of tRNA in a dose-dependent manner. The most prominent increase in protection, at A1492/3 and A1413 in helix-44 of 16S RNA, strictly required the presence of tRNA and poly(U), and the effect was correlated with the potency of the inhibitor. Radioligand binding studies with inhibitor [3H]A-424902 showed that the compound binds to tRNA, either in its charged or uncharged form. The dissociation constant for [3H]A-424902 binding to Phe-tRNAPhe was determined to be 1.8 μM, near its translation inhibition potency of 1.6 μM in a cell-free S. pneumoniae extract assay. The compound did not change the binding of radiolabeled tRNA to the 30S ribosomal subunit. Taken together, these results imply that the NRIs exert their effects on protein synthesis by structurally perturbing the tRNA/30S complex at the decoding site.
机译:新型核糖体抑制剂(NRI)是选择性抑制细菌蛋白质合成的广谱萘啶类(P.J.Dandliker等人,Antimicrob.Agents Chemother.47:3831-3839,2003)。在大肠杆菌核糖体上使用一系列NRI和化学修饰剂进行的足迹实验表明,没有证据表明可以直接保护rRNA。但是,在存在tRNA的情况下,我们发现NRI以剂量依赖性方式增强了tRNA的已知核糖体足迹模式。保护的最显着增加是在16S RNA的helix-44中的A1492 / 3和A1413处,严格要求存在tRNA和poly(U),并且该作用与抑制剂的效力相关。用抑制剂[3H] A-424902进行的放射性配体结合研究表明,该化合物以带电或不带电的形式与tRNA结合。在无细胞肺炎链球菌提取物测定中,[3H] A-424902与Phe-tRNAPhe结合的解离常数确定为1.8μM,接近其翻译抑制能力1.6μM。该化合物不会改变放射性标记的tRNA与30S核糖体亚基的结合。两者合计,这些结果暗示,NRI通过在结构上扰动解码位点的tRNA / 30S复合体,对蛋白质合成发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号